Lucror Analytics

Lucror Analytics is a leading credit and ESG research specialist and a provider of technology solutions for differentiated fixed income strategies. Our roots are in bottom-up fundamental credit analysis with a specialization in high yield corporate credits from Europe, Asia and Latin America. We are one of few research specialists integrating ESG considerations with fundamental credit research through a dedicated ESG platform. Our ESG assessment covers five key criteria: Disclosure, E,S, & G Pillars, Controversies, ESG Impact on Credit and ESG Momentum.

Recognizing the importance and value-add of Factor Investing in fixed income, Lucror developed the Smart Quant Navigator (SQN), an intuitive platform that helps clients devise and implement factor-based strategies ranging from pure quant to active fundamental, with integrated ESG.

Our company has been at the forefront of developments in the fixed income markets, identifying opportunities and consistently delivering new products and value-adding solutions to clients. Lucror has close relationships with the largest and most reputable asset managers, family offices, hedge funds, investment and wealth managers globally.

High Yield Experts

Senior Credit Analyst, Lucror Analytics

Leonard Law, CFA

Senior Credit Analyst

Credit

Medco Energi’s FY 2020 results were within expectations. The company’s earnings were only modestly impacted by the oil price crash, thanks to Medco's use of fixed-price gas contracts and hedging. Net debt improved marginally on account of its equity issuances. Looking ahead, we foresee that Medco’s EBITDA margin will improve slightly in FY 2021, given the recent recovery in oil prices. That said, we expect FCF to remain negative for the foreseeable future, which will keep its leverage elevated. As a result of its modest scale, we believe the company will continue to undertake significant exploratory capex to increase its reserves.

   Medco Energi’s FY 2020 results were within expectations. The company’s earnings were only modestly impacted by the oil price crash, thanks to Medco's use of fixed-price gas contracts and hedging. Net debt improved marginally on account of its equity issuances.    Looking ahead, we foresee that Medco’s EBITDA margin will improve slightly in FY 2021, given the recent recovery in oil prices. That said, we expect FCF to remain negative for the foreseeable future, which will keep its leverage elevated. As a result of its modest scale, we believe the company will continue to undertake significant exploratory capex to increase its reserves. 

Medco Energi - Earnings Flash - FY 2020 Results - Lucror Analytics